Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Gains from Investment Securities (2019 - 2025)

Historic Gains from Investment Securities for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $5000.0.

  • Pulmonx's Gains from Investment Securities fell 9729.73% to $5000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $459000.0, marking a year-over-year decrease of 1861.7%. This contributed to the annual value of $556000.0 for FY2024, which is 1804.67% up from last year.
  • According to the latest figures from Q3 2025, Pulmonx's Gains from Investment Securities is $5000.0, which was down 9729.73% from -$10000.0 recorded in Q2 2025.
  • Over the past 5 years, Pulmonx's Gains from Investment Securities peaked at $1.0 million during Q3 2021, and registered a low of -$10000.0 during Q2 2025.
  • For the 5-year period, Pulmonx's Gains from Investment Securities averaged around $171000.0, with its median value being $109000.0 (2022).
  • In the last 5 years, Pulmonx's Gains from Investment Securities soared by 26792.45% in 2021 and then crashed by 10943.4% in 2025.
  • Pulmonx's Gains from Investment Securities (Quarter) stood at $195000.0 in 2021, then crashed by 68.72% to $61000.0 in 2022, then surged by 68.85% to $103000.0 in 2023, then decreased by 7.77% to $95000.0 in 2024, then tumbled by 94.74% to $5000.0 in 2025.
  • Its Gains from Investment Securities was $5000.0 in Q3 2025, compared to -$10000.0 in Q2 2025 and $369000.0 in Q1 2025.